Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quantum Cyber NVFRA:4TO 39 Debt-to-Equity is 4.01 as of Dec. 2025, which is 878% above its 10-year median of 0.41. GuruFocus rates FRA:4TO with a GF Score™ of 39/100 and a GF Value™ of €4.19. The stock has 10 warning signs investors should review. Among 182 Medical Diagnostics & Research companies, Quantum Cyber NV ranks worse than 97.25% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Quantum Cyber NV's Debt-to-Equity or its related term are showing as below:
FRA:4TO'
s Debt-to-Equity Range Over the Past 10 Years
Min: -1.24 Med: 0.41 Max: 4.01
Current: 4.01
During the past 7 years, the highest Debt-to-Equity Ratio of Quantum Cyber NV was 4.01. The lowest was -1.24. And the median was 0.41.
FRA:4TO's Debt-to-Equity is ranked worse than 97.25% of 182
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.33
vs FRA:4TO: 4.01
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Quantum Cyber NV Debt-to-Equity Related Terms
Quantum Cyber NV Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Quantum Cyber NV's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4TO vs MDXH, BIOQ, ADVB: Debt-to-Equity Comparison
For the Diagnostics & Research subindustry, Quantum Cyber NV's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quantum Cyber NV Debt-to-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Quantum Cyber NV's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Quantum Cyber NV's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quantum Cyber NV (FRA:4TO) has a Debt-to-Equity of 4.01 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Quantum Cyber NV and its competitors. This is 878% above median its historical median of 0.41. According to the industry distribution chart, Quantum Cyber NV ranks #177 out of 182 companies in the Medical Diagnostics & Research industry, placing it in the top 97.3%.
Is Quantum Cyber NV's Debt-to-Equity too high?
Quantum Cyber NV's current Debt-to-Equity of 4.01 is 878% above median its 10-year median of 0.41. The Medical Diagnostics & Research industry median Debt-to-Equity is 0.33. Quantum Cyber NV's value of 4.01 is 1115.2% above this industry median. Based on the distribution chart, Quantum Cyber NV ranks #177 out of 182 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Quantum Cyber NV has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Quantum Cyber NV's Debt-to-Equity compare to MDXH and BIOQ?
According to the Medical Diagnostics & Research industry distribution chart, Quantum Cyber NV ranks #177 out of 182 companies for Debt-to-Equity. This places Quantum Cyber NV in the lower half of its industry. The industry median Debt-to-Equity is 0.33. Quantum Cyber NV's value of 4.01 is 1115.2% above this benchmark. While the company's 10-year median is 0.41 vs. the industry median of 0.33, Quantum Cyber NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Diagnostics & Research company?
The median Debt-to-Equity among Medical Diagnostics & Research companies is 0.33, based on 182 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quantum Cyber NV's current Debt-to-Equity of 4.01 is 1115.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Quantum Cyber NV and its competitors. For the Medical Diagnostics & Research industry, the median Debt-to-Equity is 0.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quantum Cyber NV's current Debt-to-Equity is 4.01, which is 878% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Cyber NV stock overvalued right now?
Quantum Cyber NV (FRA:4TO) has a current Debt-to-Equity of 4.01. The stock's GF Value™ is €4.19, compared to a current price of €8.00 — trading 90.9% above its estimated fair value. The current Debt-to-Equity is 4.01, which is 878% above median its 10-year median of 0.41 and 1115.2% above the Medical Diagnostics & Research industry median of 0.33. Quantum Cyber NV's overall GF Score™ is 39/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Quantum Cyber NV (FRA:4TO), the current Debt-to-Equity is 4.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quantum Cyber NV (FRA:4TO) Overvalued in 2026?
Based on GuruFocus' analysis, Quantum Cyber NV stock appears to be overvalued.
The current stock price of €8.00 is trading 90.9% above its estimated GF Value™ of €4.19.
Key valuation signals for FRA:4TO:
Debt-to-Equity: 4.01 (878% above median its 10-year median of 0.41)
GF Value™: €4.19 vs. price of €8.00 (90.9% above fair value)
Industry Position: 1115.2% above the Medical Diagnostics & Research median (#177 of 182)
No single metric tells the full story. See the FRA:4TO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
39GF Score
Get the complete analysis for FRA:4TO
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4TO has been successfully added to your 
